SCHEMBL7984499

SCHEMBL7984499

CC(C)Cn1cnc2[nH]c(-c3ccccc3)nc(=O)c21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.43
PDE4D Q08499 2/20 0.43
TLR7 Q9NYK1 2/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
HRH2 P25021 1/20 0.43
ADRA1D P25100 1/20 0.43
HTR2A P28223 1/20 0.43
ADRA1A P35348 1/20 0.43
NUDT1 P36639 1/20 0.43
HTR2B P41595 1/20 0.43
KCNH2 Q12809 1/20 0.43
ADORA2B P29275 3/20 0.42
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
CNOT7 Q9UIV1 4/20 0.40
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
PARN O95453 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988495 0.86 ADORA2B (0.46) ADORA2APDE4DADORA2BPDE4APDE4B
SCHEMBL7985002 0.84 ADORA2B (0.48) ADORA2APDE4DADORA2BPDE4APDE4B
SCHEMBL7975271 0.82 CNOT7 (0.56) ADORA2BCNOT7ALDH1A1SMN1; SMN2PARN
SCHEMBL7988254 0.81 ADORA2B (0.50) ADORA2APDE4DADORA2BPDE4APDE4B
SCHEMBL7985382 0.81 ADORA2B (0.46) ADORA2AADORA2BCNOT7ALDH1A1SMN1; SMN2
SCHEMBL7974620 0.80 CNOT7 (0.58) ADORA2ALMNAPOLBADORA2BCNOT7
SCHEMBL7984495 0.80 HPGD (0.47) ADORA2APDE4DTLR7LMNAPOLB
SCHEMBL7984720 0.80 CNOT7 (0.48) LMNAADORA2BCNOT7ALDH1A1SMN1; SMN2
SCHEMBL7984791 0.80 SMN1; SMN2 (0.45) LMNAPOLBCNOT7ALDH1A1SMN1; SMN2
SCHEMBL7974067 0.80 ADORA2B (0.46) ADORA2AADORA2BCNOT7ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed